EurekaMag
+ Translate
+ Most Popular
Cunninghamia lanceolata plantations in China
Mammalian lairs in paleo ecological studies and palynology
Studies on technological possibilities in utilization of anhydrous milk fat for production of recombined butter-like products
Should right-sided fibroelastomas be operated upon?
Large esophageal lipoma
Apoptosis in the mammalian thymus during normal histogenesis and under various in vitro and in vivo experimental conditions
Poissons characoides nouveaux ou non signales de l'Ilha do Bananal, Bresil
Desensitizing efficacy of Colgate Sensitive Maximum Strength and Fresh Mint Sensodyne dentifrices
Administration of fluid by subcutaneous infusion: revival of a forgotten method
Tundra mosquito control - an impossible dream?
Schizophrenia for primary care providers: how to contribute to the care of a vulnerable patient population
Geochemical pattern analysis; method of describing the Southeastern limestone regional aquifer system
Incidence of low birth weights in a hospital of Mexico City
Tabanidae
Graded management intensity of grassland systems for enhancing floristic diversity
Microbiology and biochemistry of cheese and fermented milk
The ember tetra: a new pygmy characid tetra from the Rio das Mortes, Brazil, Hyphessobrycon amandae sp. n. (Pisces, Characoidei)
Risk factors of contrast-induced nephropathy in patients after coronary artery intervention
Renovation of onsite domestic wastewater in a poorly drained soil
Observations of the propagation velocity and formation mechanism of burst fractures caused by gunshot
Systolic blood pressure in a population of infants in the first year of life: the Brompton study
Haematological studies in rats fed with metanil yellow
Studies on pasteurellosis. I. A new species of Pasteurella encountered in chronic fowl cholera
Dormancy breaking and germination of Acacia salicina Lindl. seeds
therapy of lupus nephritis. a two-year prospective study

Advances in nanocarriers enabled brain targeted drug delivery across blood brain barrier


Advances in nanocarriers enabled brain targeted drug delivery across blood brain barrier



International Journal of Pharmaceutics 559: 360-372



ISSN/ISBN: 0378-5173

PMID: 30721725

DOI: 10.1016/j.ijpharm.2019.01.056

The blood brain barrier (BBB) offers protection to the central nervous system (CNS) by maintaining homeostasis. Besides restricting the entry of harmful xenobiotics and endogenous molecules to CNS, BBB also limits the entry of therapeutic agents. Nanotechnology offers the possibility to deliver small molecules/drugs against CNS disorders across BBB. Recently, due to excellent biocompatibility, functional versatility and unique surface electrostatics properties nanodiamonds are also being explored for their drug delivery potential against BBB. Although, studies has been done to understand the mechanisms involved in drug delivery across BBB, but still, progress in the development of any functional drug delivery systems across BBB is in juvenile stages. For this purpose, the strategic developments of more potent drug delivery systems to CNS via endocytic pathways appears to be the most promising approach. Endocytic pathways are essential for communication and transport of nutrients across BBB in endothelial cells. Moreover, modifications of the nanotherapeutic agents with specific brain capillary endothelial cells targeting molecules or ligands have recently shown impressive results of successful delivery of drugs to the brain via receptor-mediated transcytosis. The current review provides a comprehensive insight in the advancements made in nanocarriers-based successful drug delivery to the CNS and their availability in clinics.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 066461657

Download citation: RISBibTeXText

Related references

Drug delivery across the blood-brain barrier: recent advances in the use of nanocarriers. Nanomedicine 15(2): 205-214, 2020

Multifunctional Nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier: perspectives on tracking and neuroimaging. Particle and Fibre Toxicology 7: 3, 2010

Crossing the Blood-Brain Barrier: Recent Advances in Drug Delivery to the Brain. Cns Drugs 31(2): 109-133, 2017

Targeted drug delivery to the brain; (blood-brain barrier, efflux, endothelium, biological transport). Journal of Drug Targeting 8(6): 353-355, 2000

Pulsed high magnetic field-induced reversible blood-brain barrier permeability to enhance brain-targeted drug delivery. Electromagnetic Biology and Medicine 2021: 1-14, 2021

Nanocarriers as Potential Drug Delivery Candidates for Overcoming the Blood-Brain Barrier: Challenges and Possibilities. Acs Omega 5(22): 12583-12595, 2020

Nanoparticle enabled drug delivery across the blood brain barrier: in vivo and in vitro models, opportunities and challenges. Current Pharmaceutical Biotechnology 14(14): 1201-1212, 2014

PLGA nanoparticles prepared by nano-emulsion templating using low-energy methods as efficient nanocarriers for drug delivery across the blood-brain barrier. Journal of Controlled Release: Official Journal of the Controlled Release Society 211: 134-143, 2015

Targeted drug delivery across the blood-brain barrier using ultrasound technique. Therapeutic Delivery 1(6): 819-848, 2010

2B-Trans technology: targeted drug delivery across the blood-brain barrier. Methods in Molecular Biology 437: 161-175, 2008

Targeted drug delivery across the blood brain barrier in Alzheimer's disease. Current Pharmaceutical Design 19(37): 6635-6646, 2013

Advances in microphysiological blood-brain barrier (BBB) models towards drug delivery. Current Opinion in Biotechnology 66: 78-87, 2020

Targeted nanoparticles for drug delivery through the blood-brain barrier for Alzheimer's disease. Journal of Controlled Release: Official Journal of the Controlled Release Society 108(2-3): 193-214, 2005

Systemic delivery of blood-brain barrier-targeted polymeric nanoparticles enhances delivery to brain tissue. Journal of Drug Targeting 23(7-8): 736-749, 2015

GDNF fusion protein for targeted-drug delivery across the human blood-brain barrier. Biotechnology and Bioengineering 100(2): 387-396, 2008